Lead Product(s) : SAN711
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Medpace, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
First-in-human Study of SAN711 in Healthy Participants
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 21, 2021
Lead Product(s) : SAN711
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Medpace, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metoprolol Succinate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 05, 2018
Lead Product(s) : Metoprolol Succinate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tesofensine
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Investigate the Pharmacokinetic Profile
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 19, 2017
Lead Product(s) : Tesofensine
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable